The Impact of Diabetes and Glucose-Lowering Therapies on Hepatocellular Carcinoma Incidence and Overall Survival.
Clin Ther. 2022 Feb;44(2):257-268. doi: 10.1016/j.clinthera.2021.12.011. Epub 2022 Jan 22.
Clin Ther. 2022.
PMID: 35078642